Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Joel Z, Stengel"'
Autor:
Joel Z, Stengel, Stephen A, Harrison
Publikováno v:
Gastroenterologyhepatology. 2(6)
Nonalcoholic fatty liver disease (NAFLD) is reaching epidemic proportions in our society and is the most common etiology for patients presenting with elevated liver enzymes. Given the significant numbers of patients presenting with NAFLD, it is impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::97824636b0474f1846d151ba9f54b661
https://pubmed.ncbi.nlm.nih.gov/28316519
https://pubmed.ncbi.nlm.nih.gov/28316519
Autor:
Cristy L. Landt, Maricela Contreras, Michael I. Asike, Stephen A. Harrison, Dawn M. Torres, Joel Z. Stengel, Janet Shaw, Christopher D. Williams
Publikováno v:
Gastroenterology. 140:124-131
Prevalence of nonalcoholic fatty liver disease (NAFLD) has not been well established. The purpose of this study was to prospectively define the prevalence of both NAFLD and nonalcoholic steatohepatitis (NASH).Outpatients 18 to 70 years old were recru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ade264a232253f58991584212188af7
https://doi.org/10.1053/j.gastro.2010.09.038
https://doi.org/10.1053/j.gastro.2010.09.038
Autor:
Sami R. Achem, Amit Agrawal, Scott E. Altschuler, Francis Amoo, Mainor R. Antillon, Matthew B.Z. Bachinski, Bruce R. Bacon, Jamie S. Barkin, David W. Bean, Major John Boger, Aaron Brzezinski, Christine Janes Bruno, Donald O. Castell, Joseph G. Cheatham, James E. Cremins, Albert J. Czaja, Dirk R. Davis, Amar R. Deshpande, John C. Deutsch, Jack A. DiPalma, Gulchin A. Ergun, Henrique J. Fernandez, James E. Fitzpatrick, Michael G. Fox, Kevin J. Franklin, Stephen R. Freeman, Gregory G. Ginsberg, John S. Goff, Seth A. Gross, Carlos Guarner, Stephen A. Harrison, Jorge L. Herrera, Kent C. Holtzmuller, Lieutenant Colonel J, David Horwhat, Jeffrey Hunt, David S. James, David P. Jones, Ryan W. Kaliney, Sergey V. Kantsevoy, Cynthia W. Ko, Kimi L. Kondo, Burton I. Korelitz, Michael J. Krier, Miranda Yeh Ku, Marcelo Kugelmas, Stephen P. Laird, Frank L. Lanza, Anthony J. LaPorta, Nicholas F. LaRusso, Brett A. Lashner, Randall E. Lee, Sum P. Lee, Martin D. McCarter, Peter R. McNally, Edgar Mehdikhani, John H. Meier, Halim Muslu, James C. Padussis, Wilson P. Pais, Theodore N. Pappas, Cyrus W. Partington, Pankaj Jay Pasricha, David A. Peura, Lori D. Prok, Matthew R. Quallick, Ramona O. Rajapakse, Kevin M. Rak, Erica N. Roberson, Ingram M. Roberts, Arvey I. Rogers, Suzanne Rose, Kevin B. Rothchild, Bruce A. Runyon, Paul D. Russ, Mark W. Russo, Travis J. Rutland, Richard E. Sampliner, Tom J. Sauerwein, Lawrence R. Schiller, Jonathan A. Schoen, Raj J. Shah, Kenneth E. Sherman, Roshan Shrestha, Maria H. Sjögren, George B. Smallfield, Major Won Song, Erik Springer, Joel Z. Stengel, Janet K. Stephens, Stephen W. Subber, Christine M. Surawicz, Jayant A. Talwalker, Shalini Tayal, Christina A. Tennyson, Selvi Thirumurthi, John J. Tiedeken, Neil W. Toribara, Dawn McDowell Torres, George Triadafilopoulos, James F. Trotter, Nimish Vakil, Arnold Wald, Michael H. Walter, George H. Warren, Jill M. Watanabe, Sterling G. West, C. Mel Wilcox, Bernard E. Zeligman, Rowen K. Zetterman, Di Zhao
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22dd41a963bfea0ffccab7fe76cbfff3
https://doi.org/10.1016/b978-0-323-06397-5.00087-3
https://doi.org/10.1016/b978-0-323-06397-5.00087-3
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 1 (2009)
Infliximab is a chimeric monoclonal antibody to human tumor necrosis factor alpha. While its use was developed in the treatment of rheumatologic diseases its effects on Crohn's disease have revolutionized the management of this chronic illness. Infli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2cea34a9d2bdb89b94949d6a289782
https://doaj.org/article/1be87c05e09e4bd7a6a1086b6a27ba60
https://doaj.org/article/1be87c05e09e4bd7a6a1086b6a27ba60
Autor:
Joel Z Stengel, David P. Jones
Publikováno v:
The American journal of gastroenterology. 103(9)
Proper colonic cleansing prior to colonoscopy is paramount to ensuring complete mucosal visualization and polyp identification. In a double-blind fashion, we compared single-dose lubiprostone (24 microg) versus placebo pretreatment prior to a split-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e777da2ecf45a1d9db798cf1cbcae3
https://pubmed.ncbi.nlm.nih.gov/18684185
https://pubmed.ncbi.nlm.nih.gov/18684185
Autor:
Hays L. Arnold, Joel Z. Stengel
Inflammatory bowel disease (IBD) often affects women around the age of conception and pregnancy. Most drugs used to treat IBD are safe in pregnancy, but physicians must consider the clinical implications of certain treatment regimens in young, fertil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68551c2452aae0fc3b5141cd0b43d525
https://europepmc.org/articles/PMC2712180/
https://europepmc.org/articles/PMC2712180/
Publikováno v:
Clinical Gastroenterology and Hepatology. 9:326-332.e1
Successful colonoscopies require good bowel preparations-poor bowel preparations can increase medical costs, rates of missed lesions, and procedure duration. The combination of polyethylene glycol (PEG) 3350 without electrolytes (MiraLAX; Schering-Pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d5e024cc8b6bca5fe74913d5a74734
https://doi.org/10.1016/j.cgh.2010.11.007
https://doi.org/10.1016/j.cgh.2010.11.007
Publikováno v:
American Journal of Gastroenterology. 105:S138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e83f7a52278b92f71d721faf2d20e60b
https://doi.org/10.14309/00000434-201010001-00375
https://doi.org/10.14309/00000434-201010001-00375